Literature DB >> 2157060

Insertion mutation of the int-1 and int-2 loci by mouse mammary tumor virus in premalignant and malignant neoplasms from the GR mouse strain.

D W Morris1, P A Barry, H D Bradshaw, R D Cardiff.   

Abstract

Mouse mammary tumor virus (MMTV)-induced mammary adenocarcinomas can develop from several different premalignant precursors common in GR mice. Insertion mutagenesis of the mammary protooncogenes int-1 and int-2 was studied in this multistep system by analyzing samples from various stages of neoplastic development for novel int-1 and int-2 restriction fragments generated by MMTV provirus integration. int-1 and int-2 insertion mutations were observed in both premalignant lesions and malignant tumors. Some of the tumors with insertion mutations were experimentally derived from insertion mutation-free premalignant precursors. Each class of neoplasm examined had a characteristic frequency of int-1 and int-2 insertion mutations; however, no correspondence was observed between neoplasm morphology and mutation of either gene. These results indicate that insertion mutation of the int-1 and int-2 loci by MMTV provirus can be involved in the earliest identifiable stages of neoplastic development as well as during progression of premalignant lesions to tumors. Insertion mutation of int-1 and int-2 is therefore not stage specific in this system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157060      PMCID: PMC249317          DOI: 10.1128/JVI.64.4.1794-1802.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice.

Authors:  K B DEOME; L J FAULKIN; H A BERN; P B BLAIR
Journal:  Cancer Res       Date:  1959-06       Impact factor: 12.701

2.  Regulation of growth and spacing of gland elements in the mammary fat pad of the C3H mouse.

Authors:  L J FAULKIN; K B DEOME
Journal:  J Natl Cancer Inst       Date:  1960-04       Impact factor: 13.506

3.  The natural history of cancer.

Authors:  L FOULDS
Journal:  J Chronic Dis       Date:  1958-07

Review 4.  The molecular genetics of cellular oncogenes.

Authors:  H E Varmus
Journal:  Annu Rev Genet       Date:  1984       Impact factor: 16.830

5.  Activation of int-1 and int-2 mammary oncogenes in hormone-dependent and -independent mammary tumors of GR mice.

Authors:  J Mester; E Wagenaar; M Sluyser; R Nusse
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

6.  Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2.

Authors:  C Dickson; R Smith; S Brookes; G Peters
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

7.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.

Authors:  R Nusse; H E Varmus
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

8.  Proviruses of mouse mammary tumor virus in normal and neoplastic tissues from GR and C3Hf mouse strains.

Authors:  J C Cohen; H E Varmus
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

9.  An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family.

Authors:  P Delli Bovi; A M Curatola; F G Kern; A Greco; M Ittmann; C Basilico
Journal:  Cell       Date:  1987-08-28       Impact factor: 41.582

10.  Sequence, topography and protein coding potential of mouse int-2: a putative oncogene activated by mouse mammary tumour virus.

Authors:  R Moore; G Casey; S Brookes; M Dixon; G Peters; C Dickson
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

View more
  7 in total

Review 1.  The comparative pathology of human and mouse mammary glands.

Authors:  R D Cardiff; S R Wellings
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

Review 2.  Multistep mouse mammary tumorigenesis through pre-neoplasia to neoplasia and acquisition of metastatic potential.

Authors:  Airo Tsubura; Katsuhiko Yoshizawa; Norihisa Uehara; Takashi Yuri; Yoichiro Matsuoka
Journal:  Med Mol Morphol       Date:  2007-03-29       Impact factor: 2.309

3.  A compendium of the mouse mammary tumor biologist: from the initial observations in the house mouse to the development of genetically engineered mice.

Authors:  Robert D Cardiff; Nicholas Kenney
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

4.  Binary system for regulating transgene expression in mice: targeting int-2 gene expression with yeast GAL4/UAS control elements.

Authors:  D M Ornitz; R W Moreadith; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

Review 5.  Genetically engineered mouse models of mammary intraepithelial neoplasia.

Authors:  R D Cardiff; D Moghanaki; R A Jensen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

6.  Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice.

Authors:  F S Lee; T F Lane; A Kuo; G M Shackleford; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

7.  Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors.

Authors:  Andrea Rosner; Keiko Miyoshi; Esther Landesman-Bollag; Xin Xu; David C Seldin; Amy R Moser; Carol L MacLeod; G Shyamala; Amy E Gillgrass; Robert D Cardiff
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.